- Home
- AXP vs ABT Comparison
AXP vs ABT Comparison
Compare AXP & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXP
- ABT
- Stock Information
- Founded
- AXP 1850
- ABT 1888
- Country
- AXP United States
- ABT United States
- Employees
- AXP N/A
- ABT N/A
- Industry
- AXP Finance: Consumer Services
- ABT Medical/Dental Instruments
- Sector
- AXP Finance
- ABT Health Care
- Exchange
- AXP Nasdaq
- ABT Nasdaq
- Market Cap
- AXP 211.3B
- ABT 237.4B
- IPO Year
- AXP N/A
- ABT N/A
- Fundamental
- Price
- AXP $298.37
- ABT $132.52
- Analyst Decision
- AXP Hold
- ABT Buy
- Analyst Count
- AXP 21
- ABT 18
- Target Price
- AXP $290.80
- ABT $140.44
- AVG Volume (30 Days)
- AXP 2.4M
- ABT 5.2M
- Earning Date
- AXP 07-18-2025
- ABT 07-17-2025
- Dividend Yield
- AXP 1.10%
- ABT 1.78%
- EPS Growth
- AXP 17.98
- ABT 139.92
- EPS
- AXP 14.32
- ABT 7.70
- Revenue
- AXP $62,049,000,000.00
- ABT $42,344,000,000.00
- Revenue This Year
- AXP $18.51
- ABT $7.53
- Revenue Next Year
- AXP $8.01
- ABT $7.69
- P/E Ratio
- AXP $20.84
- ABT $17.20
- Revenue Growth
- AXP 9.05
- ABT 5.00
- 52 Week Low
- AXP $220.43
- ABT $99.71
- 52 Week High
- AXP $326.28
- ABT $141.23
- Technical
- Relative Strength Index (RSI)
- AXP 57.12
- ABT 48.50
- Support Level
- AXP $286.15
- ABT $131.60
- Resistance Level
- AXP $299.24
- ABT $137.06
- Average True Range (ATR)
- AXP 4.76
- ABT 2.05
- MACD
- AXP -1.04
- ABT -0.27
- Stochastic Oscillator
- AXP 70.41
- ABT 31.89
About AXP American Express Company
American Express is a global financial institution, operating in about 130 countries, that provides consumers and businesses charge and credit card payment products. The company also operates a highly profitable merchant payment network. The firm operates in four segments: US consumer services, US commercial services, international card services, and global merchant and network services. In addition to payment products, the company's commercial business offers expense management tools, consulting services, and business loans.
About ABT Abbott Laboratories
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.